Ectoparasitic infestations

Current Infectious Disease Reports

Volumn 7, Issue 5, 2005, Pages 373-380

  Heukelbach, Jörg ^a   Walton, Shelley F ^b   Feldmeier, Hermann ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACARICIDE; ALBENDAZOLE; ANTIBIOTIC AGENT; ANTIPARASITIC AGENT; CINEOLE; CITRONELLAL; ESSENTIAL OIL; EUCALYPTUS OIL; HOUSE DUST ALLERGEN; IMMUNOGLOBULIN G ANTIBODY; INSECT REPELLENT; INSECTICIDE; INTERLEUKIN 1BETA; IVERMECTIN; KERATOLYTIC AGENT; MARJORAM OIL; METRIFONATE; PENNYROYAL OIL; PHENOTHRIN; PLANT EXTRACT; PYRETHRUM EXTRACT; ROSEMARY OIL; SILICONE OIL; TEA TREE OIL; TERPENE DERIVATIVE; TERPENOID DERIVATIVE; TERPINEN 4 OL; TIABENDAZOLE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANCYLOSTOMA; CLINICAL FEATURE; CLINICAL RESEARCH; CLINICAL TRIAL; DESENSITIZATION; DRUG ADMINISTRATION ROUTE; DRUG MECHANISM; ECTOPARASITE; ENDEMIC DISEASE; FILARIASIS; HELMINTHIASIS; HIGH RISK POPULATION; HUMAN; IMMUNOTHERAPY; INFESTATION; LARVA MIGRANS; LOUSE; MORBIDITY; MYIASIS; NONHUMAN; ONCHOCERCIASIS; PARASITE CONTROL; PARASITIC SKIN DISEASE; PEDICULOSIS; PEDICULUS; PREVALENCE; RECOMBINANT DNA TECHNOLOGY; REVIEW; SARCOPTES SCABIEI; SCABIES; SERODIAGNOSIS; SIDE EFFECT; SUPERINFECTION; ZOONOSIS;

EID: 26444453235     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-005-0012-2     Document Type: Review

References (65)

1. Hoy W, McDonald SP: Albuminuria: marker or target in indigenous populations. Kidney Int Suppl 2004, 66:25-31.
2. Arlian LG, Morgan MS, Estes SA, et al.: Circulating IgE in patients with ordinary and crusted scabies. J Med Entomol 2004, 41:74-77.
3. Lowenstein M, Kahlbacher H, Peschke R: On the substantial variation in serological responses in pigs to Sarcoptes scabiei var. suis using different commercially available indirect enzyme-linked immunosorbent assays. Parasitol Res 2004, 94:24-30.
4. Haas N, Wagemann B, Hermes B, et al.: Crossreacting IgG antibodies against fox mite antigens in human scabies. Arch Dermatol Res 2005, 296:327-331.
5. Walton S, Low Choy J, Bonson A, et al.: Genetically distinct dog-derived and human-derived Sarcoptes scabiei in scabies-endemic communities in northern Australia. Am J Trop Med Hyg 1999, 61:542-547.
6. Walton SF, Dougall A, Pizzutto S, et al.: Genetic epidemiology of Sarcoptes scabiei (Acari: Sarcoptidae) in northern Australia. Int J Parsitol 2004, 34:839-849.
7. Ambroise-Thomas P: Emerging parasite zoonoses: the role of host-parasite relationship. Int J Parasitol 2000, 30:1361-1367.
8. Harumal P, Morgan MS, Walton SF, et al.: Identification of a homologue of a house dust mite allergen in a cDNA library from Sarcoptes scabiei var. hominis and evaluation of its vaccine potential in a rabbit/S. scabiei var. canis model. Am J Trop Med Hyg 2003, 68:54-60.
9. Roberts LJ, Huffam SE, Walton SF, Currie BJ: Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005, 50:375-381.
10. Walton SF, Holt DC: Scabies: new future for a neglected disease. Adv Parasitol 2004, 57:309-376.
11. Tielsch JM, Beeche A: Impact of ivermectin on illness and disability associated with onchocerciasis. Trop Med Int Health 2004, 9:45-56.
12. Heukelbach J, Winter B, Wilcke T, et al.: Selective mass treatment with ivermectin to control intestinal helminthiases and parasitic skin diseases in a severely affected population. Bull World Health Organ 2004, 82:563-571.
13. Lawrence G, Leafasia J, Sheridan J, et al.: Control of scabies, skin sores and haematuria in children in the Solomon Islands: another role for ivermectin. Bull World Health Organ 2005, 83:34-42.
14. Currie BJ, Harumal P, McKinnon M, Walton SF: First documentation of in vivo and in vitro ivermectin resistance in Sarcoptes scabiei. Clin Infect Dis 2004, 39:8-12.
15. Micali G, Lacarrubba F, Tedeschi A: Videodermatoscopy enhances the ability to monitor efficacy of scabies treatment and allows optimal timing of drug application. J Eur Acad Dermatol Venereol 2004, 18:153-154.
16. Morsy TA, Rahem MA, el-Sharkawy EM, Shatat MA: Eucalyptus globulus (camphor oil) against the zoonotic scabies, Sarcoptes scabiei. J Egypt Soc Parasitol 2003, 33:47-53.
17. Walton SF, McKinnon M, Pizzutto S, et al.: Acaricidal activity of Melaleuca alternifolia (Tea Tree) oil: in vitro sensitivity of Sarcoptes scabiei var. hominis to terpinen-4-ol. Arch Dermatol 2004, 140:563-566.
18. Fischer K, Holt DC, Harumal P, et al.: Generation and characterisation of cDNA clones from Sarcoptes scabiei var. hominis for an expressed sequence tag library: identification of homologues of house dust mite allergens. Am J Trop Med Hyg 2003, 68:61-64.
19. Ljunggren EL, Nilsson D, Mausson JG: Expressed sequence tag analysis of Sarcoptes scabiei. Parasitology 2003, 127:139-145.
20. Holt DC, Fischer K, Allen GE, et al.: Mechanisms for a novel immune evasion strategy in the scabies mite Sarcoptes scabiei: A multigene family of inactivated serine proteases. J Invest Dermatol 2003, 121:1419-1424.
21. Holt DC, Fischer K, Pizzutto SJ, et al.: A multigene family of inactivated cysteine proteases in Sarcoptes scabiei. J Invest Dermatol 2004, 123:240-241.
22. Pettersson EU, Ljunggren EL, Morrison DA, Mattsson JG: Functional analysis and localisation of a delta-class glutathione S-transferase from Sarcoptes scabiei. Int J Parasitol 2005, 35:39-48.
23. Hansen RC, O'Haver J: Economic considerations associated with Pediculus humanus capitis infestation. Clin Pediatr (Phila) 2004, 43:523-527.
24. Heukelbach J, Wilcke T, Winter B, Feldmeier H: Epidemiology and morbidity of scabies and pediculosis capitis in resource-poor communities in northeast Brazil. Br J Dermatol 2005, 153:150-156.
25. Downs AM: Managing head lice in an era of increasing resistance to insecticides. Am J Clin Dermatol 2004, 5:169-177.
26. Counahan M, Andrews R, Buttner P, et al.: Head lice prevalence in primary schools in Victoria, Australia. J Paediatr Child Health 2004, 40:616-619.
27. Yang YC, Lee HS, Clark JM, Ahn YJ: Insecticidal activity of plant essential oils against Pediculus humanus capitis (Anoplura: Pediculidae). J Med Entomol 2004, 41:699-704.
28. Yang YC, Choi HY, Choi WS, et al.: Ovicidal and adulticidal activity of Eucalyptus globulus leaf oil terpenoids against Pediculus humanus capitis (Anoplura: Pediculidae). J Agric Food Chem 2004, 52:2507-2511.
29. Mumcuoglu KY, Magdassi S, Miller J, et al.: Repellency of citronella for head lice: double-blind randomized trial of efficacy and safety. Isr Med Assoc J 2004, 6:756-759.
30. Mills C, Cleary BJ, Gilmer JF, Walsh JJ: Inhibition of acetylcholinesterase by Tea Tree oil. J Pharm Pharmacol 2004, 56:375-379.
31. Takano-Lee M, Edman JD, Mullens BA, Clark JM: Home remedies to control head lice: assessment of home remedies to control the human head louse, Pediculus humanus capitis (Anoplura: Pediculidae). J Pediatr Nurs 2004, 19:393-398.
32. Pedra JH, Brandt A, Li HM, et al.: Transcriptome identification of putative genes involved in protein catabolism and innate immune response in human body louse (Pediculicidae: Pediculus humanus). Insect Biochem Mol Biol 2003, 33:1135-1143.
33. Kollien AH, Waniek PJ, Prols F, et al.: Cloning and characterization of a trypsin-encoding cDNA of the human body louse Pediculus humanus. Insect Mol Biol 2004, 13:9-18.
34. Perotti MA, Catala SS, Ormeno Adel V, et al.: The sex ratio distortion in the human head louse is conserved over time. BMC Genet 2004, 5:10.
35. Taylor MJ, Hoerauf A: A new approach to the treatment of filariasis. Curr Opin Infect Dis 2001, 14:727-731.
36. Hise AG, Gillette-Ferguson I, Pearlman E: The role of endosymbiotic Wolbachia bacteria in filarial disease. Cell Microbiol 2004, 6:97-104.
37. Shashindran CH, Gandhi IS, Krishnasamy S, Ghosh MN: Oral therapy of pediculosis capitis with cotrimoxazole. Br J Dermatol 1978, 98:699-700.
38. Witt LH, Linardi PM, Meckes O, et al.: Blood-feeding of Tunga penetrans males. Med Vet Entomol 2004, 18:439-441.
39. Feldmeier H, Heukelbach J, Eisele M, et al.: Bacterial superinfection in human tungiasis. Trop Med Int Health 2002, 7:559-564.
40. Franck S, Feldmeier H, Heukelbach J: Tungiasis: more than an exotic nuisance. Travel Med Infect Dis 2003, 1:159-166.
41. Veraldi S, Carrera C, Schianchi R: Tungiasis has reached Europe. Dermatology 2000, 201:382.
42. Muehlen M, Feldmeier H, Wilcke T, et al.: Identifying risk factors for tungiasis and heavy infestation in a resource-poor community in Northeast Brazil. Trans Roy Soc Trop Med Hyg 2005, In press.
43. Heukelbach J, Costa AML, Wilcke T, et al.: The animal reservoir of Tunga penetrans in severely affected communities of north-east Brazil. Med Vet Entomol 2004, 18:329-335.
44. Heukelbach J, Wilcke T, Harms G, Feldmeier H: Seasonal variation of tungiasis in an endemic community. Am J Trop Med Hyg 2005, 72:145-149.
45. Eisele M, Heukelbach J, van Marck E, et al.: Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: I. Natural history of tungiasis in man. Parasitol Res 2003, 90:87-99.
46. Heukelbach J, Franck S, Feldmeier H: Therapy of tungiasis: a double-blinded randomized controlled trial with oral ivermectin. Mem Inst Oswaldo Cruz 2004, 99:873-876.
47. Heukelbach J, Eisele M, Jackson A, Feldmeier H: Topical treatment of tungiasis: a randomized, controlled trial. Ann Trop Med Parasitol 2003, 97:743-749.
48. Schwalfenberg S, Witt LH, Kehr JD, et al.: Prevention of tungiasis using a biological repellent: a small case series. Ann Trop Med Parasitol 2004, 98:89-94.
49. Heukelbach J, Bonow I, Witt LH, et al.: High infection rate of Wolbachia endobacteria in the sand flea Tunga penetrans from Brazil. Acta Trop 2004, 92:225-230.
50. Feldmeier H, Witt LH, Schwalfenberg S, et al.: Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil V. Cytokine concentrations in experimentally infected Wistar rats. Parasitol Res 2004, 94:371-376.
51. Feldmeier H, Heukelbach J, Eisele M, et al.: Investigations on the biology, epidemiology, pathology and control of Tunga penetrans in Brazil: III. Cytokine levels in peripheral blood of infected humans. Parasitol Res 2003, 91:298-303.
52. Pampiglione S, Trentini M, Fioravanti ML, Gustinelli A: Differential diagnosis between Tunga penetrans (L., 1758) and T. trimamillata Pampiglione et al., 2002 (Insecta, Siphonaptera), the two species of the genus Tunga parasitic in man. Parasite 2004, 11:51-57.
53. Vobis M, D'Haese J, Mehlhorn H, et al.: Molecular biological investigations of Brazilian Tunga sp. isolates from man, dogs, cats, pigs and rats. Parasitol Res 2005, 96:107-112.
54. Heukelbach J, Wilcke T, Meier A, et al.: A longitudinal study on cutaneous larva migrans in an impoverished Brazilian township. Travel Med Infect Dis 2003, 1:213-218.
55. Heukelbach J, Wilcke T, Feldmeier H: Cutaneous larva migrans (creeping eruption) in an urban slum in Brazil. Int J Dermatol 2004, 43:511-515.
56. Tremblay A, MacLean JD, Gyorkos T, Macpherson DW: Outbreak of cutaneous larva migrans in a group of travelers. Trop Med Int Health 2000, 5:330-334.
57. Caumes E: Treatment of cutaneous larva migrans and Toxocara infection. Fundam Clin Pharmacol 2003, 17:213-216.
58. de Barros N, D'Avila MS, de Pace BS, et al.: Cutaneous myiasis of the breast: mammographic and us features-report of five cases. Radiology 2001, 218:517-520.
59. Quintanilla-Cedillo MR, Leon-Urena H, Contreras-Ruiz J, Arenas R: The value of Doppler ultrasound in diagnosis in 25 cases of furunculoid myiasis. Int J Dermatol 2005, 44:34-37.
60. Otranto D: The immunology of myiasis: parasite survival and host defense strategies. Trends Parasitol 2001, 17:176-182.
61. Otranto D, Stevens JR: Molecular approaches to the study of myiasis-causing larvae. Int J Parasitol 2002, 32:1345-1360.
62. Norwood C, Smith KJ, Neafie R, Skelton H: Are cutaneous reactions to fly larvae mediated by CD4+, TIA+ NK1.1 T Cells? J Cutan Med Surg 2001, 5:400-405.
63. Costa DC, de Tarso Ponte Pierre-Filho, Mac Cord Medina F, Mota RG, Carrera CR: Use of oral ivermectin in a patient with destructive rhino-orbital myiasis. Eye 2005, In press.
64. De Tarso P, Pierre-Filho P, Minguini N, et al.: Use of ivermectin in the treatment of orbital myiasis caused by Cochliomyia hominivorax. Scand J Infect Dis 2004, 36:503-505.
65. Nuesch R, Rahm G, Rudin W, et al.: Clustering of bloodstream infections during maggot debridement therapy using contaminated larvae of Protophormia terraenovae. Infection 2002, 30:306-309.